Collaboration will advance a next generation gene editing approach by combining Seamless’ expertise in developing highly precise and efficient ...

Seamless Therapeutics inks research collaboration with Lilly to develop programmable recombinase-based therapeutics for hearing loss: Dresden, Germany Friday, January 30, 2026, 15 ...

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

"Star Trek" heroes are clever, but so are many of its villains. With vast knowledge and inhuman capabilities, they keep ...

MIDDLETOWN – Katarina Lengyel, 24, a Middletown resident, has been dancing competitively most of her life. “Basically, I grew ...

The liver and pancreas both arise from a multipotent population of endoderm cells and share many characteristics of their early development, including the expression of common regulatory transcription ...

Hackathons using AlphaGenome and other AI models are hunting down the genetic causes of devastating conditions that have ...

The partnership aims to provide curated access to credible science, responsible innovation, and practical frameworks ...

Hall brings nearly 30 years of healthcare and life sciences financial leadership and extensive experience scaling ...

PBS NC helps your community explore new worlds and ideas through programs that educate, inform and inspire. Your ...

The Institute of Cancer Research, London, has led the development of OPTIMISE-ROR, the first structured guidance outlining how patient-reported outcomes should be used in early-stage cancer ...

Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...